Wilmot Cancer Center adds gastrointestinal, brain cancer experts

Oct 1 2007

Three specialists in gastrointestinal and brain cancers recently joined the James P. Wilmot Cancer Center at the University of Rochester Medical Center to meet the growing need in the Rochester and Upstate New York region.

“We welcome these talented physician/scientists to support our patients and expand our research,” said Richard I. Fisher, M.D. , director of the Wilmot Cancer Center and vice president for Clinical Services at the Medical Center. “Our programs are growing rapidly to accommodate the increased patient needs.”

Supriya Gupta Mohile, M.D ., was named assistant professor of Medicine in the Hematology/Oncology Unit. She is a board-certified geriatrician and oncologist with clinical expertise in treating patients with genitourinary and gastrointestinal cancers. She was previously at Columbia Presbyterian Medical Center in New York City .

She will work to develop a clinical and research program in geriatric oncology by strengthening the links between geriatrics and oncology.

A graduate of Pennsylvania State University , she earned her M.D. at Thomas Jefferson Medical School . She completed internship, residency and fellowships in hematology/oncology and geriatrics at University of Chicago Medical Center, where she also earned a master's degree in health outcomes research. Mohile's fellowship was funded by an American Society of Clinical Oncology and John Hartford Foundation initiative to train oncologists in the care of the elderly. This national initiative was led by John Bennett, professor of Hematology/Oncology, and William Hall, M.D., professor of Geriatrics.

Mohile's research interests include the evaluation of patterns of care, health outcomes, and quality of life related to treatment for systemic cancer in older patients. She has previously received an American Society of Clinical Oncology Young Investigator Award and Merit Awards that supported the preliminary data for her application. Her current work examines the relationship between disability and decision-making for older adults with prostate cancer and also utilizes the Medicare Current Beneficiary Survey to evaluate the relationship between vulnerability and cancer outcomes in the elderly. Mohile is a Hartford Geriatrics Health Outcomes Research Scholar sponsored by the American Geriatrics Society and is a recent Clinical and Translational Science Institute K-12 Awardee.

She is a member of the gastrointestinal and genitourinary oncology teams providing care for stomach, pancreatic, colorectal cancers and prostate, bladder, and kidney cancers.

Twoexperts from Memorial Sloan Kettering Cancer Center have joined the Wilmot neuro-oncology team, broadening the clinical expertise for people with brain cancers.

Nimish Mohile, M.D. , was named senior instructor of Neurology and has a joint apopinntment with the Cancer Center . He studied biology at Duke University, earned a master's degree in physiology from Georgetown University and then his M.D. at St. George's University. He completed his residency and a fellowship in neurophysiology at Northwestern University followed by a fellowship in neuro-oncology at Memorial Sloan Kettering Cancer Center.

He is interested in clinical trials for primary brain tumors and his research focuses on anti-angiogenic strategies in the treatment of gliomas.

And Joohee Sul, M.D. , was named senior instructor of Neurology. She studied at Columbia University and earned his M.D. from the University of Rochester School of Medicine and Dentistry. Sul completed her internship and residency at Strong Memorial Hospital and then went to Memorial Sloan Kettering for a fellowship in neuro-oncology.

Sul's research interests are in primary brain tumors, brain metastases, and health outcomes.

Both Mohile and Sul will be treating patients with primary brain tumors, central nervous system metastases and neurological complications of cancer. They are members of the American Academy of Neurology, Society of Neuro-Oncology, and American Society for Clinical Oncology.